US Stock Market Move | NVIDIA Corporation (NVDA.US) clears Recursion Pharmaceuticals (RXRX.US) before the market opens, causing a drop of over 13% in pre-market trading.

22:15 18/02/2026

As of the time of writing, the stock has fallen more than 13%, reporting $3.46 per share.

On Wednesday, the pre-market stock price of Recursion Pharmaceuticals (RXRX.US) plummeted, with the stock falling over 13% to $3.46 as of the time of writing. On the news front, NVIDIA Corporation (NVDA.US) submitted a 13F filing to the U.S. SEC, showing that it completely sold off its stake in Recursion Pharmaceuticals in the fourth quarter of 2025.

Palantir (PLTR.US) has reached a strategic partnership with Rackspace (RXT.US), causing the latter's stock price to surge over 216%.

Will Amazon.com, Inc. (AMZN.US), Alphabet Inc. Class C (GOOGL.US), and Microsoft Corporation (MSFT.US) emerge as the biggest winners? Anthropic could potentially pay over 80 billion US dollars in cloud fees by 2029.

US Stock Market Move | Spot gold once again rose above $5000 Coeur Mining, Inc. (CDE.US) surged more than 3.6%

Palantir (PLTR.US) has reached a strategic partnership with Rackspace (RXT.US), causing the latter's stock price to surge over 216%.

US Stock Market Move | Spot gold once again rose above $5000 Coeur Mining, Inc. (CDE.US) surged more than 3.6%